SARS-CoV-2 Spike RBD Recombinant Nanobody Online Inquiry

• Cat#:
• ADC-56137A

• Product Name:
• SARS-CoV-2 Spike RBD Recombinant Nanobody

• Synonym:
• S; 2; Spike glycoprotein; S glycoprotein; E2; Peplomer protein)

• Description:
• The recombinant antibody against S (Spike glycoprotein) was produced using the Recombinant Human Novel Coronavirus Spike glycoprotein(S) (319-541aa) as the immunogen. This antibody exists as a non-conjugated isotype VHH fusion with human IgG1 Fc, Affinity-chromatography purified. This antibody has been validated on ELISA, GICA, Neutralising.

• Immunogen:
• Recombinant Human Novel Coronavirus Spike glycoprotein(S) (319-541aa)

• Species Reactivity:
• Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV)

• Isotype:
• VHH fusion with human IgG1 Fc

• Application:
• ELISA, GICA, Neutralising

• Storage Buffer:
• 0.03% Proclin 300Constituents: 50% Glycerol, 0.01M PBS, pH 7.4

• Storage:
• Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

• Clonality:
• Monoclonal

• Target Name:
• S (Spike glycoprotein)

• Form:
• Liquid

• Immunogen Species:
• Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV)

• Immunogen Sequence:
• Complete sequences for the immunogen, target protein, and peptides are available upon request.

• Uniprot-ID:
• P0DTC2

• Purification Method:
• Affinity-chromatography purified